Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes (2020)
- Authors:
- USP affiliated authors: CAVALEIRO, ANA MERCEDES DE SOUSA - FM ; MACHADO, UBIRATAN FABRES - ICB ; PASSARELLI, MARISA - FM ; NEGRO, SONIA JANCAR - ICB
- Unidades: FM; ICB
- DOI: 10.1155/2020/5704713
- Subjects: FISIOLOGIA; IMUNOLOGIA; GLICEMIA; LEUCOTRIENOS; SISTEMA NERVOSO AUTÔNOMO; NEUROPATIAS DIABÉTICAS; DIABETES MELLITUS; EXPRESSÃO GÊNICA; NEFROPATIAS; INFLAMAÇÃO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Mediators of Inflammation
- ISSN: 1466-1861
- Volume/Número/Paginação/Ano: V. 2020, Art. 5704713, 9 p., 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BEZERRA, Daniele Perreira dos Santos et al. Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes. Mediators of Inflammation, p. 9 , 2020Tradução . . Disponível em: https://doi.org/10.1155/2020/5704713. Acesso em: 13 fev. 2026. -
APA
Bezerra, D. P. dos S., Ribeiro Junior, L. F., Monteiro, M. B., Admoni, S. N., Perez, R. V., Cavaleiro, A. M. de S., et al. (2020). Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes. Mediators of Inflammation, 9 . doi:10.1155/2020/5704713 -
NLM
Bezerra DP dos S, Ribeiro Junior LF, Monteiro MB, Admoni SN, Perez RV, Cavaleiro AM de S, Machado CG, Machado UF, Passarelli M, Jancar S, Giannella MLC. Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes [Internet]. Mediators of Inflammation. 2020 ; 9 .[citado 2026 fev. 13 ] Available from: https://doi.org/10.1155/2020/5704713 -
Vancouver
Bezerra DP dos S, Ribeiro Junior LF, Monteiro MB, Admoni SN, Perez RV, Cavaleiro AM de S, Machado CG, Machado UF, Passarelli M, Jancar S, Giannella MLC. Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes [Internet]. Mediators of Inflammation. 2020 ; 9 .[citado 2026 fev. 13 ] Available from: https://doi.org/10.1155/2020/5704713 - Association of single nucleotide polymorphisms in the gene encoding GLUT1 and diabetic nephropathy in Brazilian patients with type 1 diabetes mellitus
- Palmitate-induced Slc2a4/GLUT4 downregulation in L6 muscle cells: evidence of inflammatory and endoplasmic reticulum stress involvement
- AGEs-induced and endoplasmic reticulum stress/inflammation-mediated regulation of GLUT4 expression and atherogenesis in diabetes mellitus
- Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients
- Possible role of a radiation-induced p53 mutation in a Nelson’s syndrome patient with a fatal outcome
- Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas
- Nuclear Factor-Kappa-B mediates the advanced glycation end product-induced repression of Slc2a4 gene expression in 3T3-L1 adipocytes
- Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis
- Oleic and linoleic fatty acids downregulate Slc2a4/GLUT4 expression via NFKB and SREBP1 in skeletal muscle cells
- Hormetic modulation of hepatic insulin sensitivity by advanced glycation end products
Informações sobre o DOI: 10.1155/2020/5704713 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Leukotriene pathway activ... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
